BUZZ-YD Bio rises as it signs U.S. regulatory partnership
Reuters
Feb 25
BUZZ-YD Bio rises as it signs U.S. regulatory partnership
** Shares of Biotechnology company YD Bio YDES.O rise 3.97% to $8.38 premarket
** Co says it signed a U.S. regulatory partnership with YC Biotech, an Asia‑based technical and regulatory support firm, to help drug and device makers navigate FDA approvals
** Co says it will act as YC Biotech's exclusive U.S. representative, handling FDA communication and guiding clients from early meetings to final submissions
** YDES says the deal marks a shift toward a broader platform model that may expand into Europe
** Co says partnership expected to boost service offerings and support client growth
** Shares up ~8% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.